Lantern Pharma

Every September organizations have worked to raise awareness for childhood cancer by participating in childhood cancer awareness month.  Organizations such as the American Childhood Cancer Organization (ACCO), St. Judes Children’s Research Hospital, The Greehey Children’s Cancer...

When most people think of lung cancer, they often picture a smoker. But CDC data indicates that between 10% and 20% of new lung cancer diagnoses in the United States each year are in patients who’ve smoked fewer than 100 cigarettes in their lifetime. When people who have never smoked get non-...

Photo by National Cancer Institute on Unsplash Panna Sharma, CEO and President of Lantern Pharma Inc. (NASDAQ: LTRN), was a guest speaker at Benzinga’s All Access on Jan. 28, 2022. Panna discussed how Lantern Pharma is attempting to transform oncology drug development through data. Via AI and...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Artificial intelligence is one of the most fascinating and powerful technological advances to come along over the past decade. The idea...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharma company, debuted as a public company on June 15, 2020. In merely the seven...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. From 2000 to 2015, oncology drug development has had a success rate of only 3.4%. And while significant progress has been made in this...